Skip to main content

AUTOVIA A LOS LISOSOMAS: DIRIGIENDO A MACROFAGOS INFECTADOS

SAF2017-83575-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE LEÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum, Venenos de la Topoisomerasa IB inducen la fosforilación de la histona H2A como respuesta al daño del ADN en Leishmania infantum

  • Gutiérrez Corbo, María del Camino
  • Álvarez Velilla, Raquel
  • Reguera Torres, Rosa María
  • García Estrada, Carlos
  • Cushman, Mark
  • Balaña Fouce, Rafael
  • Pérez Pertejo, Maria Yolanda
[EN] DNA topoisomerases are considered consolidated druggable targets against diseases produced by trypanosomatids. Several reports indicated that indenoisoquinolines, a family of non-camptothecinic based topoisomerase poisons, have a strong leishmanicidal effect both in vitro and in vivo in murine models of visceral leishmaniasis. The antileishmanial effect of the indenoisoquinolines implies several mechanisms that include the stabilization of the cleavage complex, histone H2A phosphorylation and DNA fragmentation. A series of 20 compounds with the indenoisoquinoline scaffold and several substituents at positions N6, C3, C8 and C9, were tested both in promastigotes and in intramacrophage splenic amastigotes obtained from an experimental murine infection. The antileishmanial effect of most of these compounds was within the micromolar or submicromolar range. In addition, the introduction of an N atom in the indenoisoquinoline ring (7-azaindenoisoquinolines) produced the highest selectivity index along with strong DNA topoisomerase IB inhibition, histone H2A phosphorylation and DNA-topoisomerase IB complex stabilization. This report shows for the first time the effect of a series of synthetic indenoisoquinolines on histone H2A phosphorylation, which represents a primary signal of double stranded DNA break in genus Leishmania., SI, This research was supported in part by Ministerio de Economía y Competitividad (MINECO, AEI, FEDER, UE; [MINECO: AGL2016- 79813-C2-1R and SAF2017-83575-R]), and Junta de Castilla y León cofinanced by FEDER, UE (LE020P17). CGC is supported by a scholarship of Junta de Castilla y León cofinanced by FEDER. We thank University of Leon for providing funding to cover publication expenses.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents, Actividad frente a Leishmania de nuevos derivados híbridos de tetrahidroquinolina y quinolina con sustituyentes de fósforo

  • Tejería, Ana
  • Pérez Pertejo, Maria Yolanda
  • Reguera Torres, Rosa María
  • Carbajo Andrés, Rubén
  • Balaña Fouce, Rafael
  • Alonso Pérez, Concepción Estíbaliz
  • Martín Encinas, Endika
  • Selas, Asier
  • Rubiales, Gloria
  • Palacios, Francisco
[EN] Heterocyclic compounds, such as hybrid tetrahydroquinoline and quinoline derivatives with phosphorated groups, have been prepared by multicomponent cycloaddition reaction between phosphorus-substituted anilines, aldehydes and styrenes. The antileishmanial activity of these compounds has been evaluated on both promastigotes and intramacrophagic amastigotes of Leishmania infantum. Good antileishmanial activity of functionalized tetrahydroquinolines 4a, 5a, 6b and quinoline 8b has been observed with similar activity than the standard drug amphotericin B and close selective index (SI between 43 and 57) towards L. infantum amastigotes to amphotericin B. Special interest shows tetrahydroquinolylphosphine sulfide 5a with an EC50 value (0.61 ± 0.18 μM) similar to the standard drug amphotericin B (0.32 ± 0.05 μM) and selective index (SI = 56.87). In addition, compound 4c shows remarkable inhibition on Leishmania topoisomerase IB. Parallel theoretical study of stereoelectronic properties, application of docking-based virtual screening methods, along with molecular electrostatic potential and predictive druggability analyses are also reported., SI, Financial support from the Ministerio de Economía y Competitividad (MINECO, AEI, FEDER, UE) [MINECO: AGL2016-79813-C2-1R, SAF2017-83575-R and CTQ2015-67871-R], Gobierno Vasco (GV, IT 992-16) and the Junta de Castilla y León cofinanced by FEDER, UE [LE020P17] is gratefully acknowledged. Technical and human support provided by IZO-SGI, SGIker (UPV/EHU, MICINN, GV/EJ, ERDF and ESF) is gratefully acknowledged.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB

  • Pérez Pertejo, Maria Yolanda
  • Escudero Martínez, José Miguel
  • Reguera Torres, Rosa María
  • Balaña Fouce, Rafael
  • García, Pablo A.
  • Jambrina, Pablo G.
  • San Feliciano Martín, Arturo
[EN] Leishmania is the aethiological agent responsible for the visceral leishmaniasis, a serious parasite-borne disease widely spread all over the World. The emergence of resistant strains makes classical treatments less effective; therefore, new and better drugs are necessary. Naphthoquinones are interesting compounds for which many pharmacological properties have been described, including leishmanicidal activity. This work shows the antileishmanial effect of two series of terpenyl-1,4-naphthoquinones (NQ) and 1,4-anthraquinones (AQ) obtained from natural terpenoids, such as myrcene and myrceocommunic acid. They were evaluated both in vitro and ex vivo against the transgenic iRFP-Leishmania infantum strain and also tested on liver HepG2 cells to determine their selectivity indexes. The results indicated that NQ derivatives showed better antileishmanial activity than AQ analogues, and among them, compounds with a diacetylated hydroquinone moiety provided better results than their corresponding quinones. Regarding the terpenic precursor, compounds obtained from the monoterpenoid myrcene displayed good antiparasitic efficiency and low cytotoxicity for mammalian cells, whereas those derived from the diterpenoid showed better antileishmanial activity without selectivity. In order to explore their mechanism of action, all the compounds have been tested as potential inhibitors of Leishmania type IB DNA topoisomerases, but only some compounds that displayed the quinone ring were able to inhibit the recombinant enzyme in vitro. This fact together with the docking studies performed on LTopIB suggested the existence of another mechanism of action, alternative or complementary to LTopIB inhibition. In silico druglikeness and ADME evaluation of the best leishmanicidal compounds has shown good predictable druggability, SI, Financial support came from Spanish MINECO (CTQ2015-68175-R, AGL2016-79813-C2-1-R, AGL2016-79813-C2-2-R and SAF2017-83575-R), ISCIII-RICET Network (RD12/0018/0002) and Consejería de Educación de la Junta de Castilla y León (LE020P17) co-financed by the Fondo Social Europeo of the European Union (FEDER-EU). P. G. J. acknowledges funding by Fundación Salamanca Ciudad de Cultura y Saberes (’‘Programme for attracting scientific talent to Salamanca’‘)
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Miltefosine and nifuratel combination: a promising therapy for the treatment of leishmania donovani visceral leishmaniasis

  • Melcón Fernández, Estela
  • Galli, Giulio
  • García Estrada, Carlos
  • Balaña Fouce, Rafael
  • Reguera Torres, Rosa María
  • Pérez Pertejo, Maria Yolanda
[EN] Visceral leishmaniasis is a neglected vector-borne tropical disease caused by Leishmania donovani and Leishmania infantum that is endemic not only in East African countries, but also in Asia, regions of South America and the Mediterranean Basin. For the pharmacological control of this disease, there is a limited number of old and, in general, poorly adherent drugs, with a multitude of adverse effects and low oral bioavailability, which favor the emergence of resistant pathogens. Pentavalent antimonials are the first-line drugs, but due to their misuse, resistant Leishmania strains have emerged worldwide. Although these drugs have saved many lives, it is recommended to reduce their use as much as possible and replace them with novel and more friendly drugs. From a commercial collection of anti-infective drugs, we have recently identified nifuratel-a nitrofurantoin used against vaginal infections-as a promising repurposing drug against a mouse model of visceral leishmaniasis. In the present work, we have tested combinations of miltefosine-the only oral drug currently used against leishmaniasis-with nifuratel in different proportions, both in axenic amastigotes from bone marrow and in intracellular amastigotes from infected Balb/c mouse spleen macrophages, finding a potent synergy in both cases. In vivo evaluation of oral miltefosine/nifuratel combinations using a bioimaging platform has revealed the potential of these combinations for the treatment of this disease., SI, This research was partially funded by MINECO; SAF2017-83575-R and PID 2020-119031RB-100 to R.M.R. E.M.-F. is contracted with EU PRIMA (PCI2022-132925); G.G. is recipient of FPI scholarship (PRE 2021 096909) supported by AEI
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains

  • Gutiérrez Corbo, María del Camino
  • Domínguez Asenjo, Bárbara
  • Pérez Pertejo, Maria Yolanda
  • García Estrada, Carlos
  • Bello, Felio J.
  • Balaña Fouce, Rafael
  • Reguera Torres, Rosa María
[EN] Neglected Tropical Diseases (NTDs) represent a serious threat to humans, especially for those living in poor or developing countries. Leishmanianiosis is considered a zoonotic NTD transmitted by the bite of female phlebotomine sandflies, and is manifested mainly as a visceral form (caused by L. infantum and L. donovani) and a cutaneous form (caused by many species including L. major, L. tropica and L. braziliensis). Although it is now known that sexual reproduction occurs in these parasites, more studies are necessary to characterize the ability of Leishmania to generate hybrids, which may represent an important mechanism for virulence, drug resistance or adaptation to the host immune system. Therefore, several experiments were conducted to generate either intraclonal or interspecies hybrids in vitro. Results demonstrated that hybrids can be formed even with outcrosses between parasites causing visceral and cutaneous forms of the disease. Characterization of hybrids in terms of ploidy, kDNA content, growth rate and infection capacity provide important information about sexual reproduction in these parasites., SI, : C.G.C (LE255-16) and B.D.A (LE208-17) are recipients of Junta de Castilla y Leo´n (JCyL) and European Social Found (ESF)’s Fellowships Scheme for Doctoral Training Programs. This research was funded by MINECO; SAF2017- 83575-R to RMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Antiparasitic effect of synthetic aromathecins on Leishmania infantum

  • Reguera Torres, Rosa María
  • Álvarez Velilla, Raquel
  • Domínguez Asenjo, Bárbara
  • Gutiérrez Corbo, María del Camino
  • Balaña Fouce, Rafael
  • Cushman, Mark
  • Pérez Pertejo, Maria Yolanda
[EN} Background Canine leishmaniasis is a zoonotic disease caused by Leishmania infantum, being the dogs one of the major reservoirs of human visceral leishmaniasis. DNA topology is a consolidated target for drug discovery. In this regard, topoisomerase IB – one of the enzymes controlling DNA topology – has been poisoned by hundreds of compounds that increase DNA fragility and cell death. Aromathecins are novel molecules with a multiheterocyclic ring scaffold that have higher stability than camptothecins. Results Aromathecins showed strong activity against both forms of L. infantum parasites, free-living promastigotes and intra-macrophagic amastigotes harbored in ex vivo splenic explant cultures obtained from infected BALB/c mice. However, they prevented the relaxation activity of leishmanial topoisomerase IB weakly, which suggests that the inhibition of topoisomerase IB partially explains the antileishmanial effect of these compounds. The effect of aromathecins was also studied against a strain resistant to camptothecin, and results suggested that the trafficking of these compounds is not through the ABCG6 transporter. Conclusions Aromathecins are promising novel compounds against canine leishmaniasis that can circumvent potential resistances based on drug efflux pumps., SI, This research had the financial support of: Ministerio de Economía y Competitividad (MINECO, AEI, FEDER, UE) [MINECO: AGL2016–79813-C2-1R, SAF2017–83575-R]. Junta de Castilla y León cofinanced by FEDER UE [LE020P17, Grant UIC108]. The funding body does not participate in the design of the study; collection, analysis and interpretation of data and in writing the manuscript.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates

  • García Estrada, Carlos
  • Pérez Pertejo, Maria Yolanda
  • Domínguez Asenjo, Bárbara
  • Holanda, Vanderlan Nogueira
  • Murugesan, Sankaranarayanan
  • Martínez Valladares, María
  • Balaña Fouce, Rafael
  • Reguera Torres, Rosa María
[EN] Due to the lack of specific vaccines, management of the trypanosomatid-caused neglected tropical diseases (sleeping sickness, Chagas disease and leishmaniasis) relies exclusively on pharmacological treatments. Current drugs against them are scarce, old and exhibit disadvantages, such as adverse effects, parenteral administration, chemical instability and high costs which are often unaffordable for endemic low-income countries. Discoveries of new pharmacological entities for the treatment of these diseases are scarce, since most of the big pharmaceutical companies find this market unattractive. In order to fill the pipeline of compounds and replace existing ones, highly translatable drug screening platforms have been developed in the last two decades. Thousands of molecules have been tested, including nitroheterocyclic compounds, such as benznidazole and nifurtimox, which had already provided potent and effective effects against Chagas disease. More recently, fexinidazole has been added as a new drug against African trypanosomiasis. Despite the success of nitroheterocycles, they had been discarded from drug discovery campaigns due to their mutagenic potential, but now they represent a promising source of inspiration for oral drugs that can replace those currently on the market. The examples provided by the trypanocidal activity of fexinidazole and the promising efficacy of the derivative DNDi-0690 against leishmaniasis seem to open a new window of opportunity for these compounds that were discovered in the 1960s. In this review, we show the current uses of nitroheterocycles and the novel derived molecules that are being synthesized against these neglected diseases, SI, This collaborative research was partially funded by MINECO; SAF2017-83575-R to RMR
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery

  • Álvarez Velilla, Raquel
  • Gutiérrez Corbo, María del Camino
  • Punzón, Carmen
  • Pérez Pertejo, Maria Yolanda
  • Balaña Fouce, Rafael
  • Fresno, Manuel
  • Reguera Torres, Rosa María
[EN] Background Visceral leishmaniasis is a neglected parasitic disease with no vaccine available and its pharmacological treatment is reduced to a limited number of unsafe drugs. The scarce readiness of new antileishmanial drugs is even more alarming when relapses appear or the occurrence of hard-to-treat resistant strains is detected. In addition, there is a gap between the initial and late stages of drug development, which greatly delays the selection of leads for subsequent studies. Methodology/Principal findings In order to address these issues, we have generated a red-shifted luminescent Leishmania infantum strain that enables long-term monitoring of parasite burden in individual animals with an in vivo limit of detection of 10 6 intracellular amastigotes 48 h postinfection. For this purpose, we have injected intravenously different infective doses (10 4 —5x10 8 ) of metacyclic parasites in susceptible mouse models and the disease was monitored from initial times to 21 weeks postinfection. The emission of light from the target organs demonstrated the sequential parasite colonization of liver, spleen and bone marrow. When miltefosine was used as proof-of-concept, spleen weight parasite burden and bioluminescence values decreased significantly. Conclusions In vivo bioimaging using a red-shifted modified Leishmania infantum strain allows the appraisal of acute and chronic stage of infection, being a powerful tool for accelerating drug development against visceral leishmaniasis during both stages and helping to bridge the gap between early discovery process and subsequent drug development., SI, Funding: RAV received a postdoctoral fellowship from Tres Cantos Open Lab Foundation CBM-ULe_TC178 TCOLF (http://www.openlabfoundation.org). MCGC received a predoctoral fellowship from Consejería de Educación de la Junta de Castilla y León (http://www.educa.jcyl.es/es). RBF was granted by Ministerio de Economía y Competitividad del Gobierno de España, AGL2016-79813-C2-1R (http://www.mineco.gob.es/portal/site/mineco/) and Consejería de Educación de la Junta de Castilla y León LE020P17 (http://www.educa.jcyl.es/es). MFE was granted by Tres Cantos Open Lab Foundation CBM-ULe_TC178 TCOLF (http://www.openlabfoundation.org). RRT was funded by Ministerio de Economía y Competitividad del Gobierno de España, SAF2017-83575-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Mannose-Decorated dendritic polyglycerol nanocarriers drive antiparasitic drugs to Leishmania infantum-Infected Macrophages

  • Vossen, Laura I.
  • Domínguez Asenjo, Bárbara
  • Gutiérrez Corbo, María del Camino
  • Pérez Pertejo, Maria Yolanda
  • Balaña Fouce, Rafael
  • Reguera Torres, Rosa María
  • Calderón, Marcelo
[EN] Macrophages are hosts for intracellular pathogens involved in numerous diseases including leishmaniasis. They express surface receptors that may be exploited for specific drug-targeting. Recently, we developed a PEGylated dendritic polyglycerol-based conjugate (PG-PEG) that colocalizes with intracellular parasite. We hereby study the effect of surface decoration with mannose units on the conjugates' targeting ability toward leishmania intracellular parasites. Murine and human macrophages were exposed to fluorescently labeled mannosylated PG-PEG and uptake was quantified by flow cytometry analysis. Nanocarriers bearing five mannose units showed the highest uptake, which varied between 30 and 88% in the population in human and murine macrophages, respectively. The uptake was found to be dependent on phagocytosis and pinocytosis (80%), as well as clathrin-mediated endocytosis (79%). Confocal microscopy showed that mannosylated PG-PEGs target acidic compartments in macrophages. In addition, when both murine and human macrophages were infected and treated, colocalization between parasites and mannosylated nanoconjugates was observed. Leishmania-infected bone marrow-derived macrophages (BMM) showed avidity by mannosylated PG-PEG whereas non-infected macrophages rarely accumulated conjugates. Moreover, the antileishmanial activity of Amphotericin B was kept upon conjugation to mannosylated PG-PEG through a pH-labile linker. This study demonstrates that leishmania infected macrophages are selectively targeted by mannosylated PEGylated dendritic conjugates., SI, C.G.-C. and B.D.-A. scholarships were supported by JCyL and FSE. This collaborative research was funded by MINECO; SAF2017-83575-R to R.M.R. M.C. gratefully acknowledges financial support from the Bundesministerium für Bildung und Forschung (BMBF) through the NanoMatFutur award (ThermoNanogele, 13N12561), the Freie Universität Berlin Focus Area Nanoscale and IKERBASQUE—Basque Foundation for Science.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

DNA flowerstructure co-localizes with human pathogens in infected macrophages

  • Franch, Oskar
  • Gutiérrez Corbo, María del Camino
  • Domínguez Asenjo, Bárbara
  • Boesen, Thomas
  • Jensen, Pia Bomholt
  • Nejsum, Lene N
  • Keller, Josephine Geertsen
  • Nielsen, Simon Pagaard
  • Singh, Prakruti R
  • Jha, Rajiv Kumar
  • Nagaraja, Valakunja
  • Balaña Fouce, Rafael
  • Ho, Yi-Ping
  • Reguera Torres, Rosa María
  • Knudsen, Birgitta Ruth
[EN] Herein, we characterize the cellular uptake of a DNA structure generated by rolling circle DNA amplification. The structure, termed nanoflower, was fluorescently labeled by incorporation of ATTO488-dUTP allowing the intracellular localization to be followed. The nanoflower had a hydrodynamic diameter of approximately 300 nanometer and was non-toxic for all mammalian cell lines tested. It was internalized specifically by mammalian macrophages by phagocytosis within a few hours resulting in specific compartmentalization in phagolysosomes. Maximum uptake was observed after eight hours and the nanoflower remained stable in the phagolysosomes with a half-life of 12 h. Interestingly, the nanoflower co-localized with both Mycobacterium tuberculosis and Leishmania infantum within infected macrophages although these pathogens escape lysosomal degradation by affecting the phagocytotic pathway in very different manners. These results suggest an intriguing and overlooked potential application of DNA structures in targeted treatment of infectious diseases such as tuberculosis and leishmaniasis that are caused by pathogens that escape the human immune system by modifying macrophage biology., SI, B.R.K. was funded by Marie & M.B. Richters Fond, Aage og Ejnar Danielsens Fond, The Novo Nordisk Foun- dation, Minister Erna Hamiltons Legat for Videnskab og Kunst, Civilingeniør Frode V. Nyegaard og Hustrus Fond, Augustinus Fonden and Aage og Johanne Louise- Hansens Fond; R.B.F. and R.M.R. was supported by Ministerio de Econom´ıa y Competitividad (MINECO) [SAF2017-83575-R]; C.G.C. and B.D.A. were supported by scholarships of Junta de Castilla y Le ´on co-financed by FSE; Research in V.N.’s laboratory is supported by grants from Department of Biotechnology, Government of India [MCB/VNR/DBT/496]; Life science research, education and training at JNCSAR [BT/INF/22/SP27679/2018]; V.N. is a recipient of J.C. Bose fellowship of Department of Science and Technology, Government of India; Y.P.H. received funding from Endowment Fund Research Grant provided by the United College, the Chinese University of Hong Kong [CA11278]; L.N.N. was funded by the Lundbeck Foundation [R37-A3461]; Carlsberg Foundation [2013 01 0566, 2012 01 0589]; MEMBRANES (Aarhus University, Denmark) for microscope equipment; O.F. re- ceived funding from the Carlsberg Foundation. Funding for open access charge: Novo Nordisk Foundation. Conflict of interest statement. None declared
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Ex vivo phenotypic screening of two small repurposing drug collections identifies nifuratel as a potential new treatment against visceral and cutaneous leishmaniasis

  • Domínguez Asenjo, Bárbara
  • Gutiérrez Corbo, María del Camino
  • Álvarez Bardón, María
  • Pérez Pertejo, Maria Yolanda
  • Balaña Fouce, Rafael
  • Reguera Torres, Rosa María
[EN] Leishmaniases are vector-borne neglected diseases caused by single-celled parasites. The search for new antileishmanial drugs has experienced a strong boost thanks to the application of bioimaging to phenotypic screenings based on intracellular amastigotes. Mouse splenic explants infected with fluorescent strains of Leishmania are proven tools of drug discovery, where hits can be easily transferred to preclinical in vivo models. We have developed a two-staged platform for antileishmanial drugs. First, we screened two commercial collections of repurposing drugs with a total of 1769 compounds in ex vivo mouse splenocytes infected with an infrared emitting Leishmania infantum strain. The most active and safest compounds were scaled-up to in vivo models of chronic Leishmania donovani visceral leishmaniasis and Leishmania major cutaneous leishmaniasis. From the total of 1769 compounds, 12 hits with selective indices >35 were identified, and 4 of them were tested in vivo in a model of L. donovani visceral leishmaniasis. Nifuratel, a repurposed synthetic nitrofuran, when administered orally at 50 mg/kg bw once or twice a day for 10 days, caused >80% reduction in the parasitic load. Furthermore, the intralesional administration of nifuratel in a model of cutaneous leishmaniasis by L. major produced the parasitological cure. From the previous results we have deduced the great capacity of mouse splenic explants to identify new hits, a model which could be easily transferred to in vivo models, as well as the potential use of nifuratel as an alternative to the current treatment of cutaneous leishmaniasis., SI, The authors would like to thank Miguel Fernández Fernández and other members of the Animal House of University of León for their impeccable care of the animals. We would also like to thank Carlos García Estrada for his support in editing the manuscript. The first author B.D.A. (LE208−17), C.G.C. (LE255−16), and M.A.B. (LE051−18) are recipients of Junta de Castilla y Leon (JCyL) and European Social Found (ESF)’s Fellowships Scheme for Doctoral Training Programs. The IVIS Spectrum Imaging System was purchased as part of INFRARED program (2018-ULE1) of Junta de Castilla y Leon (JCyL) funded by European Regional Development Fund (ERDF). This collaborative research was funded by MINECO; SAF2017−83575-R to R.M.R.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication

Subcutaneous immunization of leishmania HSP70-II null mutant line reduces the severity of the experimental visceral leishmaniasis in BALB/c mice

  • Solana, José Carlos
  • Ramírez, Laura
  • Cook, Emma C. L.
  • Hernández-García, Elena
  • Sacristán, Silvia
  • Martín, M. Elena
  • González, Víctor Manuel
  • Reguera, Rosa María
  • Balaña-Fouce, Rafael
  • Fresno, Manuel
  • Requena, José María
  • Iborra, Salvador
  • Soto, Manuel
Leishmania infantum parasites cause a severe form of visceral leishmaniasis in human and viscerocutaneous leishmaniasis in dogs. Recently, we reported that immunization with an attenuated L. infantum cell line, lacking the hsp70-II gene, protects against the development of murine cutaneous leishmaniasis. In this work, we analyzed the vaccine potential of this cell line towards the long-term protection against murine visceral leishmaniasis. This model shows an organ-dependent evolution of the disease. The infection can resolve in the liver but chronically affect spleen and bone marrow. Twelve weeks after subcutaneous administration of attenuated L. infantum, Bagg Albino (BALB/c) mice were challenged with infective L. infantum parasites expressing the luciferase-encoding gene. Combining in vivo bioimaging techniques with limiting dilution experiments, we report that, in the initial phase of the disease, vaccinated animals presented lower parasite loads than unvaccinated animals. A reduction of the severity of liver damage was also detected. Protection was associated with the induction of rapid parasite-specific IFN-γ production by CD4+ and CD8+ T cells. However, the vaccine was unable to control the chronic phase of the disease, since we did not find differences in the parasite burdens nor in the immune response at that time point., The research made for this study was supported in Spain by grants from Ministerio de Ciencia e Innovación FISPI11/00095, SAF2017-83575-R and FISPI14/00366 (FEDER FUNDING) and the Fondo de Investigaciones Sanitarias (ISCIII-RETICRD16/0027/0008-FEDER). S.I. is funded by RYC-2016-19463 and RTI2018-343 094484-B-I00 from Ministerio de Ciencia e Innovación. Institutional grants from the Fundación Ramón Areces and Banco de Santander to the CBMSO are also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Screening marine natural products for new drug leads against trypanosomatids and malaria

  • Álvarez-Bardón, M.
  • Pérez-Pertejo, Yolanda
  • Ordóñez, C.
  • Sepúlveda-Crespo, D.
  • Carballeira, N.M.
  • Tekwani, B.L.
  • Murugesan, S.
  • Martínez Valladares, María
  • García-Estrada, Carlos
  • Reguera, R.M.
  • Balaña-Fouce, Rafael
42 páginas, 15 figuras, 1 tabla., Neglected Tropical Diseases (NTD) represent a serious threat to humans, especially for those living in poor or developing countries. Almost one-sixth of the world population is at risk of suffering from these diseases and many thousands die because of NTDs, to which we should add the sanitary, labor and social issues that hinder the economic development of these countries. Protozoan-borne diseases are responsible for more than one million deaths every year. Visceral leishmaniasis, Chagas disease or sleeping sickness are among the most lethal NTDs. Despite not being considered an NTD by the World Health Organization (WHO), malaria must be added to this sinister group. Malaria, caused by the apicomplexan parasite Plasmodium falciparum, is responsible for thousands of deaths each year. The treatment of this disease has been losing effectiveness year after year. Many of the medicines currently in use are obsolete due to their gradual loss of efficacy, their intrinsic toxicity and the emergence of drug resistance or a lack of adherence to treatment. Therefore, there is an urgent and global need for new drugs. Despite this, the scant interest shown by most of the stakeholders involved in the pharmaceutical industry makes our present therapeutic arsenal scarce, and until recently, the search for new drugs has not been seriously addressed. The sources of new drugs for these and other pathologies include natural products, synthetic molecules or repurposing drugs. The most frequent sources of natural products are microorganisms, e.g., bacteria, fungi, yeasts, algae and plants, which are able to synthesize many drugs that are currently in use (e.g. antimicrobials, antitumor, immunosuppressants, etc.). The marine environment is another well-established source of bioactive natural products, with recent applications against parasites, bacteria and other pathogens which affect humans and animals. Drug discovery techniques have rapidly advanced since the beginning of the millennium. The combination of novel techniques that include the genetic modification of pathogens, bioimaging and robotics has given rise to the standardization of High-Performance Screening platforms in the discovery of drugs. These advancements have accelerated the discovery of new chemical entities with antiparasitic effects. This review presents critical updates regarding the use of High-Throughput Screening (HTS) in the discovery of drugs for NTDs transmitted by protozoa, including malaria, and its application in the discovery of new drugs of marine origin., Financial support from the Ministerio de Economía y Competitividad (MINECO, AEI, FEDER, UE)[MINECO: AGL2016-79813-C2-1R and SAF2017-83575-R], the Junta de Castilla y León co-financed by FEDER, UE[LE020P17] to RBF and DBT, New Delhi [BT/IN/Spain/39/SM/2017-18] to MS are gratefully acknowledged. MAB(LE051-18) and DSC (LE020P17) are supported by a scholarship from the Junta de Castilla y León co-financed byFSE. MMV is supported by the Spanish “Ramon y Cajal” Programme Ministry of Economy and Competitiveness(Ministerio de Economia y Competitividad; MMV, RYC-2015-18368). We thank University of Leon for providingfunding to cover publication expenses.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Reproduction in Trypanosomatids: Past and Present

  • Gutiérrez-Corbo, C.
  • Domínguez-Asenjo, Bárbara
  • Martínez Valladares, María
  • Pérez-Pertejo, Yolanda
  • García-Estrada, Carlos
  • Balaña-Fouce, Rafael
  • Reguera, R. M.
15 páginas, 2 figuras., Diseases caused by trypanosomatids (Sleeping sickness, Chagas disease, and leishmaniasis) are a serious public health concern in low-income endemic countries. These diseases are produced by single-celled parasites with a diploid genome (although aneuploidy is frequent) organized in pairs of non-condensable chromosomes. To explain the way they reproduce through the analysis of natural populations, the theory of strict clonal propagation of these microorganisms was taken as a rule at the beginning of the studies, since it partially justified their genomic stability. However, numerous experimental works provide evidence of sexual reproduction, thus explaining certain naturally occurring events that link the number of meiosis per mitosis and the frequency of mating. Recent techniques have demonstrated genetic exchange between individuals of the same species under laboratory conditions, as well as the expression of meiosis specific genes. The current debate focuses on the frequency of genomic recombination events and its impact on the natural parasite population structure. This paper reviews the results and techniques used to demonstrate the existence of sex in trypanosomatids, the inheritance of kinetoplast DNA (maxi- and minicircles), the impact of genetic exchange in these parasites, and how it can contribute to the phenotypic diversity of natural populations., This research was partially funded by MINECO; SAF2017-83575-R. The first author CGC (LE255-16) as well as BDA (LE208-17) are recipients of Junta de Castilla y Leon (JCyL) and European Social Found (ESF)’s Fellowships Scheme for Doctoral Training Programs. MMV is funded by the Spanish “Ramon y Cajal” Programme (RYC-2015-18368).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

In vivo toxicity and efficacy of two diamine and one benzimidazole derivatives against the gastrointestinal nematode Haemonchus contortus

  • Valderas García, Elora
  • Castilla Gómez de Agüero, Verónica
  • Cambra Pelletjá, María
  • del Olmo, Esther
  • Balaña-Fouce, Rafael
  • Martínez Valladares, María
Trabajo presentado al: 28th International Conference of the World Association for the Advancement of Veterinary Parasitology (WAAVP). Dublín. Virtual meeting., MINECO (AEI, FEDER, UE): AGL2016-79813-C2-1R/2R and SAF2017-83575-R and Junta de Castilla y León (JCyL) cofinanced by FEDER, UE [LE020p17]. EVG is funded by JCyL and MMV by Ramón y Cajal Programme (RYC-2015-18368)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Further investigations of nitroheterocyclic compounds as potential antikinetoplastid drug candidates

  • García-Estrada, C.
  • Pérez-Pertejo, Y.
  • Domínguez-Asenjo, B.
  • Holanda, V.N.
  • Murugesan, S.
  • Martínez Valladares, María
  • Balaña-Fouce, Rafael
  • Reguera, R.M.
32 páginas, 7 figuras., Due to the lack of specific vaccines, management of the trypanosomatid-caused neglected tropical diseases (sleeping sickness, Chagas disease and leishmaniasis) relies exclusively on pharmacological treatments. Current drugs against them are scarce, old and exhibit disadvantages, such as adverse effects, parenteral administration, chemical instability and high costs which are often unaffordable for endemic low-income countries. Discoveries of new pharmacological entities for the treatment of these diseases are scarce, since most of the big pharmaceutical companies find this market unattractive. In order to fill the pipeline of compounds and replace existing ones, highly translatable drug screening platforms have been developed in the last two decades. Thousands of molecules have been tested, including nitroheterocyclic compounds, such as benznidazole and nifurtimox, which had already provided potent and effective effects against Chagas disease. More recently, fexinidazole has been added as a new drug against African trypanosomiasis. Despite the success of nitroheterocycles, they had been discarded from drug discovery campaigns due to their mutagenic potential, but now they represent a promising source of inspiration for oral drugs that can replace those currently on the market. The examples provided by the trypanocidal activity of fexinidazole and the promising efficacy of the derivative DNDi-0690 against leishmaniasis seem to open a new window of opportunity for these compounds that were discovered in the 1960s. In this review, we show the current uses of nitroheterocycles and the novel derived molecules that are being synthesized against these neglected diseases., This collaborative research was partially funded by MINECO; SAF2017-83575-R to RMR., Peer reviewed